PRESENTING COMPANIES 2026
DNB Carnegie//Back Bay is proud to invite US and Nordic life science companies with exceptional technologies or advances to present to an audience of US healthcare investors at the 10th Annual Nordic-American Healthcare Conference 2026 next spring in New York.
Over the years, NAHC presenting companies have showcased cutting-edge technologies designed to address critical unmet needs in disease treatment and significantly advance healthcare delivery.
The following companies will present their healthcare technologies/updates at NAHC 2026
Investors please connect with our planning team to request a 1x1 meeting.
-
AddLife (OM:ALIF B)
SWEDEN
Diagnostics/Commercial
Presented by:
Fredrik Dalborg, Chief Executive Officer
Christina Rubenhag, CFO
Company Information > -
ALK (CPSE:ALK B)
DENMARK
Immunology/Commercial
Presented by:
Per Plotnikof Vice President Corporate Communications, Investor Relations and Strategic Planning
Company Information > -
Ambu (CPSE:AMBU B)
DENMARK
Diagnostics/Commercial
Presented by:
Anders Hjort, Head of Investor Relations
Company Information > -
BioArctic (OM:BIOA B)
SWEDEN
Neurology/Commercial
Presented by:
Anders Martin-Löf, Chief Financial Officer
Company Information > -
BioGaia
SWEDEN
Probiotics/Commercial
Presented by: Theresa Agnew, Chief Executive Officer and President
Company Information > -
Bonesupport (OM:BONEX)
SWEDEN
Orthopedics/Commercial
Presented by:
Torbjörn Sköld, Chief Executive Officer
Håkan Johansson, Chief Financial Officer
Company Information > -
Camurus (OM:CAMX)
SWEDEN
CNS/Pain, Commercial
Presented by:
Fredrik Tiberg, President & Chief Executive Officer
Company Information > -
Embla Medical (CPSE:EMBLA)
ICELAND
Orthopedics/Commercial
Presented by:
Klaus Sindahl, Head of Investor Relations
Company Information > -
F2G (Private)
US-UK
Rare/Fungal/Commercial
Presented by:
Francesco Maria Lavino, Chief Executive Officer
Company Information > -
Humacyte (NASDAQ: HUMA)
UNITED STATES
Cardiovascular/Commercial
Presented by:
Laura Niklason, Founder, President and Chief Executive Officer
Company Information > -
Ligand Pharmaceuticals
UNITED STATES
Biopharma Development/Commercial
Presented by:
Paul J. Hadden, Senior Vice President, Investments and Business Development
Company Information > -
Lundbeck (CPSE:HLUN B)
DENMARK
Neurology/Commercial
Presented by:
Johan Luthman, Executive Vice President, R&D
Company Information > -
Medistim
NORWAY
Cardio/Surgery/Commercial
Presented by:
Kari Eian Krogst, Chief Executive Officer
Company Information > -
New Amsterdam Pharma (NASDAQGM:NAMS)
NETHERLANDS
Diagnostics/Phase III
Presented by:
Michael Davidson, Chief Executive Officer
Company Information > -
NMD Pharma (Private)
DENMARK
Neurology/Phase II
Presented by:
Thomas Holm Pedersen, Chief Executive Officer
Company Information > -
Novo Nordisk (CPSE:NOVO B)
DENMARK
Metabolic/Commercial
Presented by:
Frederik Taylor Pitter Investor Relations Director, North America
Company Information > -
Orion (HLSE:ORNBV)
FINLAND
Oncology, CNS/Pain/Commerical
Presented by:
Tuukka Hirvonen, Head of Investor Relations
Company Information > -
Pharmacosmos (Private)
DENMARK
Hematology/Commercial
Presented by:
Thomas B. Riisager, Executive Vice President, Business Development & Strategy
Company Information > -
Photocure (OB:PHO)
NORWAY
Diagnostics/Commercial
Presented by:
Dan Schneider, President and Chief Executive Officer
Company Information > -
Pulse BioSciences (NASDAQCM:PLSE)
UNITED STATES
Dermatology/Commercial
Presented by:
Paul LaViolette, Chief Executive Officer & Co-Chairman of the Board of Directors
Company Information > -
SOBI (OM:SOBI)
SWEDEN
Hematology/Commercial
Presented by:
Duane H. Barnes, President, Head of Sobi North America
Company Information > -
Vicore Pharma (OM:VICO)
SWEDEN
Respiratory/Phase II
Presented by:
Megan Richards, Vice President of Investor Relations
Company Information > -
Vitrolife (OM:VITR)
SWEDEN
Women’s Health/Commercial
Presented by:
Pär Ihrskog, Chief Financial Officer
Company Information > -
XVIVO (OM:XVIVO)
SWEDEN
Organ Transplant/Commerical
Presented by:
Kristoffer Nordström, Chief Financial Officer
Company Information >